banner2

Getting started
N-Ethyl-N-Methylcarbamoyl Chloride CAS 42252-34-6

N-Ethyl-N-Methylcarbamoyl Chloride CAS 42252-34-6 - China Manufacturers, Suppliers, Factory

N-Ethyl-N-Methylcarbamoyl Chloride CAS 42252-34-6, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

CAS 42252-34-6 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — N-Ethyl-N-Methylcarbamoyl Chloride CAS 42252-34-6 Rivastigmine Tartrate Intermediate Purity >99.0% (GC)
Read More

D-(+)-Galactosamine Hydrochloride CAS 1772-03-8 Purity >99.0% (HPLC)

D-Mannosamine Hydrochloride CAS 5505-63-5 Assay >99.0% (HPLC)

D-(+)-Glucosamine Hydrochloride CAS 66-84-2 Assay 98.0%~102.0% Factory

3-Chloropropionyl Chloride CAS 625-36-5 Purity >98.5% (GC) Factory

Nickel(II) Chloride Hexahydrate CAS 7791-20-0 Ni ≥22.0% Factory

Palonosetron Hydrochloride CAS 135729-62-3 Purity >99.0% (HPLC) (T) API Factory

banner4

Top Selling Products

Related Blog
Reviews

Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) -Shanghai Ruifu Chemical Co., Ltd. will attend with customers.

Shanghai Ruifu Chemical Co., Ltd. will attend the The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) with customers. The 87th China International ...

2022.12.01 09:02:44
2022.10.10 02:14:54
2022.09.21 09:26:25
2022.09.08 20:38:04
2022.06.20 17:16:33
2022.02.14 04:49:39

related search